CN103301400A - Traditional Chinese medicinal composition for treating chronic atrophic gastritis and preparation method of traditional Chinese medicinal composition - Google Patents
Traditional Chinese medicinal composition for treating chronic atrophic gastritis and preparation method of traditional Chinese medicinal composition Download PDFInfo
- Publication number
- CN103301400A CN103301400A CN2013102021629A CN201310202162A CN103301400A CN 103301400 A CN103301400 A CN 103301400A CN 2013102021629 A CN2013102021629 A CN 2013102021629A CN 201310202162 A CN201310202162 A CN 201310202162A CN 103301400 A CN103301400 A CN 103301400A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- herba
- traditional chinese
- chinese medicinal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 208000016644 chronic atrophic gastritis Diseases 0.000 title claims abstract description 24
- 239000000203 mixture Substances 0.000 title claims abstract description 16
- 238000002360 preparation method Methods 0.000 title claims description 7
- 239000003814 drug Substances 0.000 claims abstract description 41
- 229940079593 drug Drugs 0.000 claims abstract description 9
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims abstract description 6
- 235000014375 Curcuma Nutrition 0.000 claims abstract description 3
- 239000007788 liquid Substances 0.000 claims description 9
- 241000628997 Flos Species 0.000 claims description 7
- 235000003143 Panax notoginseng Nutrition 0.000 claims description 7
- 241000180649 Panax notoginseng Species 0.000 claims description 7
- 241000244155 Taenia Species 0.000 claims description 7
- 238000003756 stirring Methods 0.000 claims description 6
- 239000000341 volatile oil Substances 0.000 claims description 6
- 238000001914 filtration Methods 0.000 claims description 3
- 239000002994 raw material Substances 0.000 claims description 3
- 239000006228 supernatant Substances 0.000 claims description 3
- 244000164439 Curcuma angustifolia Species 0.000 claims description 2
- 241000245240 Lonicera Species 0.000 claims description 2
- 241001522129 Pinellia Species 0.000 claims description 2
- 241001038563 Pseudostellaria Species 0.000 claims description 2
- 241000233948 Typha Species 0.000 claims description 2
- 210000002784 stomach Anatomy 0.000 abstract description 9
- 208000024891 symptom Diseases 0.000 abstract description 7
- 230000001225 therapeutic effect Effects 0.000 abstract description 5
- 241001529821 Agastache Species 0.000 abstract 1
- 241000205585 Aquilegia canadensis Species 0.000 abstract 1
- 244000037364 Cinnamomum aromaticum Species 0.000 abstract 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 abstract 1
- 244000183685 Citrus aurantium Species 0.000 abstract 1
- 235000007716 Citrus aurantium Nutrition 0.000 abstract 1
- 244000164480 Curcuma aromatica Species 0.000 abstract 1
- 240000009138 Curcuma zedoaria Species 0.000 abstract 1
- 235000003405 Curcuma zedoaria Nutrition 0.000 abstract 1
- 241000735527 Eupatorium Species 0.000 abstract 1
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 240000001659 Oldenlandia diffusa Species 0.000 abstract 1
- 244000131316 Panax pseudoginseng Species 0.000 abstract 1
- 235000003181 Panax pseudoginseng Nutrition 0.000 abstract 1
- 235000014676 Phragmites communis Nutrition 0.000 abstract 1
- 241001522232 Pinellia ternata Species 0.000 abstract 1
- 241001162994 Rugosus Species 0.000 abstract 1
- 244000272264 Saussurea lappa Species 0.000 abstract 1
- 235000006784 Saussurea lappa Nutrition 0.000 abstract 1
- 240000001949 Taraxacum officinale Species 0.000 abstract 1
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 abstract 1
- 241000301400 Trogopterus Species 0.000 abstract 1
- 240000001398 Typha domingensis Species 0.000 abstract 1
- 239000001812 curcuma zedoaria berg. rosc. Substances 0.000 abstract 1
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 abstract 1
- 210000003608 fece Anatomy 0.000 abstract 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 abstract 1
- 230000007794 irritation Effects 0.000 abstract 1
- 235000011477 liquorice Nutrition 0.000 abstract 1
- 230000002195 synergetic effect Effects 0.000 abstract 1
- 229940126680 traditional chinese medicines Drugs 0.000 abstract 1
- 235000019509 white turmeric Nutrition 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 13
- 230000036407 pain Effects 0.000 description 6
- 208000007882 Gastritis Diseases 0.000 description 5
- 235000019789 appetite Nutrition 0.000 description 5
- 230000036528 appetite Effects 0.000 description 5
- 230000004596 appetite loss Effects 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 206010017758 gastric cancer Diseases 0.000 description 4
- 235000021266 loss of appetite Nutrition 0.000 description 4
- 208000019017 loss of appetite Diseases 0.000 description 4
- 238000011084 recovery Methods 0.000 description 4
- 206010003694 Atrophy Diseases 0.000 description 3
- 208000005718 Stomach Neoplasms Diseases 0.000 description 3
- 230000037444 atrophy Effects 0.000 description 3
- 235000008216 herbs Nutrition 0.000 description 3
- 201000011549 stomach cancer Diseases 0.000 description 3
- 208000004300 Atrophic Gastritis Diseases 0.000 description 2
- 208000036495 Gastritis atrophic Diseases 0.000 description 2
- 206010054949 Metaplasia Diseases 0.000 description 2
- 230000003187 abdominal effect Effects 0.000 description 2
- 210000001156 gastric mucosa Anatomy 0.000 description 2
- 210000004907 gland Anatomy 0.000 description 2
- 206010020718 hyperplasia Diseases 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 230000015689 metaplastic ossification Effects 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 210000000712 G cell Anatomy 0.000 description 1
- 102100021022 Gastrin Human genes 0.000 description 1
- 108010052343 Gastrins Proteins 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- 102000057297 Pepsin A Human genes 0.000 description 1
- 108090000284 Pepsin A Proteins 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000002318 cardia Anatomy 0.000 description 1
- AOXOCDRNSPFDPE-UKEONUMOSA-N chembl413654 Chemical compound C([C@H](C(=O)NCC(=O)N[C@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@H](CCSC)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC=1C=CC=CC=1)C(N)=O)NC(=O)[C@@H](C)NC(=O)[C@@H](CCC(O)=O)NC(=O)[C@@H](CCC(O)=O)NC(=O)[C@@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H]1N(CCC1)C(=O)CNC(=O)[C@@H](N)CCC(O)=O)C1=CC=C(O)C=C1 AOXOCDRNSPFDPE-UKEONUMOSA-N 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 208000023652 chronic gastritis Diseases 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 208000010643 digestive system disease Diseases 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000004211 gastric acid Anatomy 0.000 description 1
- 208000010749 gastric carcinoma Diseases 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000002439 hemostatic effect Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 229940111202 pepsin Drugs 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 201000000498 stomach carcinoma Diseases 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a traditional Chinese medicinal composition for treating chronic atrophic gastritis. The traditional Chinese medicinal composition is prepared from the following crude medicines in parts by weight: 40 parts of radix pseudostellariae, 50 parts of dendrobe, 5 parts of pseudo-ginseng, 40 parts of curcuma zedoary, 40 parts of radix curcumae, 20 parts of radix paeoniae alba, 40 parts of oldenlandia diffusa, 45 parts of dandelion, 45 parts of sculellaria barbata, 10 parts of mangnolia officinalis, 7 parts of agastache rugosus, 7 parts of eupatorium, 7 parts of pericarpium citri reticulatae, 8 parts of pinellia ternata, 8 parts of costus root, 8 parts of fructus amomi, 8 parts of cattail pollen, 8 parts of trogopterus dung, 4 parts of liquorice, 10 parts of cassia twig, 10 parts of caulis bambusae in taeniam, 30 parts of reed rhizome, 10 parts of bitter orange, 10 parts of radix ophiopogonis and 20 parts of honeysuckle. The traditional Chinese medicinal composition is rational in formula, and various traditional Chinese medicines take a synergistic action to enhance therapeutic effect which, in comparison with Western medicine, is more excellent; the traditional Chinese medicinal composition treats both symptoms and root causes, and is high in cure rate, low in recurrence rate, light in irritation to stomach; the composition relieves body burden.
Description
Technical field
The invention belongs to technical field of Chinese medicines, specifically a kind of Chinese medicine composition and preparation method for the treatment of chronic atrophic gastritis.
Background technology
In digestive system disease, gastritis is comparatively common disease, account for clinical patient affected by inspection's 13%, and sickness rate raises along with the increase at age, gastric epithelial after the infringement of suffering repeatedly so that intrinsic body of gland atrophy or the disappearance of mucosa, produce pathological changes, the normal companion of serious atrophic gastritis sees that intestinal epithelial metaplasia or atypical hyperplasia are arranged, might develop into gastric cancer, gastric mucosa atrophy is intestinal epithelial metaplasia atypical hyperplasia gastric cancer one by one one by one one by one, be considered to a kind of progressive process that gastric cancer occurs, so people are called a kind of of disease before the Stomach Carcinomas with atrophic gastritis in recent years.
Chronic atrophic gastritis is a kind of commonly encountered diseases, refers to that gastric mucosa loss of function atrophy and change are living, often involves cardia, reduce with the forfeiture of G cell and gastrin secretion, also can involve body of stomach, with the forfeiture of secreting acid gland, cause gastric acid, the minimizing of pepsin and endogenous factors.
The medicine that is used for the treatment of chronic atrophic gastritis has many kinds; Generally be divided into Chinese medicine and Western medicine, adopt the western medicine chronic atrophic gastritis, side effect is larger, and larger to the infringement of human body, therapeutic effect is undesirable; Because Chinese medicine has little, the eutherapeutic characteristics of side effect, therefore favored by people.
Summary of the invention
The problem to be solved in the present invention is for above problem, provides the cure rate high relapse rate low a kind of Chinese medicine composition and preparation method for the treatment of chronic atrophic gastritis.
For addressing the above problem, the technical solution adopted in the present invention is:
A kind of Chinese medicine composition for the treatment of chronic atrophic gastritis is got the crude drug of following parts by weight: 40 parts of Radix Pseudostellariaes, 50 parts of Herba Dendrobiis, 5 parts of Radix Notoginseng, 40 parts of Rhizoma Curcumae, 40 parts of Radix Curcumaes, 20 parts of the Radix Paeoniae Albas, 40 parts of Herba Hedyotidis Diffusaes, 45 parts of Herba Taraxacis, 45 parts of Herba Scutellariae Barbataes, 10 parts of Cortex Magnoliae Officinalis, 7 parts of Herba Pogostemoniss, 7 parts of Herba Eupatoriis, 7 parts of Pericarpium Citri Reticulataes, 8 parts of the Rhizoma Pinelliaes, 8 parts of the Radix Aucklandiae, 8 parts of Fructus Amomis, 8 parts of Pollen Typhaes, 8 parts of Oletum Trogopteroris, 4 parts in Radix Glycyrrhizae; 10 parts of Ramulus Cinnamomi, 10 parts of Caulis Bambusae In Taenia, 30 parts of Rhizoma Phragmitiss, 10 parts of Fructus Aurantiis, 10 parts of Radix Ophiopogonis, 20 parts of Flos Loniceraes.
A kind of preparation method for the treatment of the Chinese medicine composition of chronic atrophic gastritis may further comprise the steps:
1) gets Herba Dendrobii, Radix Notoginseng, the Radix Paeoniae Alba, Herba Hedyotidis Diffusae, Herba Taraxaci, Herba Scutellariae Barbatae, Cortex Magnoliae Officinalis, Herba Pogostemonis, Herba Eupatorii, the Rhizoma Pinelliae, the Radix Aucklandiae, Fructus Amomi, Pollen Typhae, Oletum Trogopterori, Radix Glycyrrhizae, Ramulus Cinnamomi, Caulis Bambusae In Taenia, Rhizoma Phragmitis, Radix Ophiopogonis, the Flos Lonicerae of above-mentioned weight portion, the decocting that adds 10 times of total raw material medicine weight boils, leach medicinal liquid, get medicinal liquid A;
After Radix Pseudostellariae, Rhizoma Curcumae, Radix Curcumae, Pericarpium Citri Reticulatae, the Fructus Aurantii of 2) getting above-mentioned weight portion extracted volatile oil respectively, the decocting that medicinal residues add up 5 times of crude drug weight boiled, and decoction liquor is centrifugal, gets supernatant, gets extracting solution B;
3) merge above-mentioned medicinal liquid A and extracting solution B, stir, get extracting solution C after the filtration;
When 4) extracting solution C being heated to 70 degrees centigrade, add step 2) volatile oil that makes, stir, make medicine.
Radix Pseudostellariae, Herba Dendrobii, Radix Notoginseng, Rhizoma Curcumae, Fructus Amomi, Ramulus Cinnamomi, Radix Ophiopogonis, Flos Lonicerae had the effect that strengthens the spleen and stomach; Radix Curcumae has the analgesic effect, the Radix Paeoniae Alba, Herba Hedyotidis Diffusae, Herba Taraxaci, Herba Scutellariae Barbatae, the effect of heat-clearing and toxic substances removing, warming the meridian and promoting blood circulation; Cortex Magnoliae Officinalis, Herba Pogostemonis, Herba Eupatorii, Pericarpium Citri Reticulatae, the Rhizoma Pinelliae, the Radix Aucklandiae, Pollen Typhae, Oletum Trogopterori, Radix Glycyrrhizae; Effect pleasant, hemostatic analgesia that Caulis Bambusae In Taenia, Rhizoma Phragmitis have.
Through clinical trial, the present embodiment has good curative effect to the treatment chronic atrophic gastritis, is difficult for recurrence, and has no side effect, and does not develop immunity to drugs, and be 15 days each course for the treatment of, can cure after taking 2 to 3 courses for the treatment of, and cure rate reaches more than 83%, and relapse rate is lower.
The rational compatibility of the present invention's process, the synergism of each Chinese medicine, therapeutic effect is remarkable, compares with using Western medicine, is better than Western medicine, takes stopgap measures and effects a permanent cure, and cure rate is high, and relapse rate is low, and treatment by Chinese herbs is less to the zest of stomach, alleviates body burden.
The specific embodiment
Embodiment, a kind of Chinese medicine composition for the treatment of chronic atrophic gastritis is got the crude drug of following parts by weight: Radix Pseudostellariae 40 grams, Herba Dendrobii 50 grams, Radix Notoginseng 5 grams, Rhizoma Curcumae 40 grams, Radix Curcumae 40 grams, the Radix Paeoniae Alba 20 grams, Herba Hedyotidis Diffusae 40 grams, Herba Taraxaci 45 grams, Herba Scutellariae Barbatae 45 grams, Cortex Magnoliae Officinalis 10 grams, Herba Pogostemonis 7 grams, Herba Eupatorii 7 grams, Pericarpium Citri Reticulatae 7 grams, the Rhizoma Pinelliae 8 grams, the Radix Aucklandiae 8 grams, Fructus Amomi 8 grams, Pollen Typhae 8 grams, Oletum Trogopterori 8 grams, Radix Glycyrrhizae 4 grams; Ramulus Cinnamomi 10 grams, Caulis Bambusae In Taenia 10 grams, Rhizoma Phragmitis 30 grams, Fructus Aurantii 10 grams, restrain Radix Ophiopogonis 10, Flos Lonicerae 20 grams.
A kind of preparation method for the treatment of the Chinese medicine composition of chronic atrophic gastritis may further comprise the steps:
1) gets Herba Dendrobii, Radix Notoginseng, the Radix Paeoniae Alba, Herba Hedyotidis Diffusae, Herba Taraxaci, Herba Scutellariae Barbatae, Cortex Magnoliae Officinalis, Herba Pogostemonis, Herba Eupatorii, the Rhizoma Pinelliae, the Radix Aucklandiae, Fructus Amomi, Pollen Typhae, Oletum Trogopterori, Radix Glycyrrhizae, Ramulus Cinnamomi, Caulis Bambusae In Taenia, Rhizoma Phragmitis, Radix Ophiopogonis, the Flos Lonicerae of above-mentioned weight, the decocting that adds 10 times of total raw material medicine weight boils, leach medicinal liquid, get medicinal liquid A;
After Radix Pseudostellariae, Rhizoma Curcumae, Radix Curcumae, Pericarpium Citri Reticulatae, the Fructus Aurantii of 2) getting above-mentioned weight extracted volatile oil respectively, the decocting that medicinal residues add up 5 times of crude drug weight boiled, and decoction liquor is centrifugal, gets supernatant, gets extracting solution B;
3) merge above-mentioned medicinal liquid A and extracting solution B, stir, get extracting solution C after the filtration;
When 4) extracting solution C being heated to 70 degrees centigrade, add step 2) volatile oil that makes, stir, make medicine.
The medicine that makes is divided into two parts, and a minute morning and evening takes, and 15 days is a course for the treatment of, and can fully recover general 2-3 course for the treatment of, and period in a medicine is avoided pungent meat or fish,
For further investigating clinical efficacy and the safety of the present embodiment medicine, we have selected the case of 300 routine chronic gastritiss that the treatment curative effect of medicine of the present invention is carried out clinical trial.
The patient of 300 routine chronic atrophic gastritis is divided into two groups at random, every group of 150 examples.In the matched group, male's 81 examples, women's 69 examples; 30～40 years old age, 20 examples, 41～50 years old 51 example, 51～60 years old 48 example, 61～70 years old 28 example, 3 examples more than 70 years old; In the treatment group, male's 85 examples, women's 65 examples; 30～40 years old age, 18 examples, 41～50 years old 52 example, 51～60 years old 45 example, 61～70 years old 29 example, 6 examples more than 70 years old.
Two groups of cases are Epidemiological Analysis by statistics at aspects such as sex, age, the courses of disease, has comparability.
Matched group adopts appropriate exercise, and rational diet adopts traditional Western medicine to treat; The oral medicine of the present invention for the treatment of group divides to take night and morning, and takes 3 courses for the treatment of.
Criterion of therapeutical effect: cure: clinical symptoms, sign disappear, the gastritis transference cure, and stomach is comfortable, has no adverse reaction.Produce effects: clinical symptoms, sign obviously alleviate, and the gastritis symptom obviously alleviates, and the symptom such as have a stomach-ache obviously alleviates, and hemogram is normal.Effectively: clinical symptoms, sign alleviate, the gastritis sx↓.Invalid: clinical symptoms, sign are not improved.Relapse rate: the probability that within 1 year, recurs again after curing.Curative effect comparision result such as table one after two groups of cases are treated.
Table one
| Group | The example number | Cure n(%) | Produce effects n(%) | Effective n(%) | Invalid n(%) | Relapse rate n(%) |
| Matched group | 150 | 100（66.7） | 120（80.0） | 130（86.7） | 20（13.3） | 20（33.3） |
| Treatment group | 150 | 125（83.3） | 145（96. 7） | 148（98.7） | 2（1.33） | 13（8.7） |
By above-mentioned contrast, can find out and use treatment by Chinese herbs chronic atrophic gastritis of the present invention, therapeutic effect is remarkable, compares with using Western medicine, is better than Western medicine, takes stopgap measures and effects a permanent cure, and cure rate is high, and relapse rate is low, and treatment by Chinese herbs is less to the zest of stomach, alleviates body burden.
The present invention has good curative effect to the treatment chronic atrophic gastritis, is difficult for recurrence, and has no side effect, and does not develop immunity to drugs, and be 15 days each course for the treatment of, can cure after taking 2 to 3 courses for the treatment of, and cure rate reaches more than 83.3%, and relapse rate is lower, only is about 8.7%.
Some patients were healing case is as follows:
The field, the woman, 52 years old, suffer from chronic atrophic gastritis, be distending pain, dull pain, dull pain, severe pain or angor during outbreak, the scorching hot or noisy discomfort of the conscious gastral cavilty of patient section.Loss of appetite usually appears, even without appetite, though or appetite feed aftersensation gastral cavilty section's distension discomfort or dyspepsia are arranged, give the present embodiment after 2 courses for the treatment of, patient's transference cure, recovery from illness, so far recurrence.
Jiang, man, 32 years old, suffer from chronic atrophic gastritis, gastral cavilty section distension is uncomfortable, and some patients feel that there is the sense of obstruction in the vexed or gastral cavilty section of stomach painful abdominal mass, abdominal part, side of body flank, chest are also felt distension, and belch is frequent, the scorching hot or noisy discomfort of the conscious gastral cavilty of patient section, loss of appetite usually appears, even without appetite, give the present embodiment after 3 courses for the treatment of, patient's transference cure, recovery from illness, so far not recurrence.
The river, woman 45 years old suffers from chronic atrophic gastritis, the scorching hot or noisy discomfort of the conscious gastral cavilty of patient section, loss of appetite usually occurs, even without appetite, stomach severe pain or angor during outbreak give the present embodiment after 2 courses for the treatment of, patient's transference cure, recovery from illness, so far not recurrence.
Weigh certain, man 50 years old suffers from chronic atrophic gastritis, scorching hot or the noisy discomfort of the conscious gastral cavilty of patient section, loss of appetite usually appears, even without appetite, stomach severe pain or angor during outbreak, abdominal part, side of body flank, chest are also felt distension, belch is frequent, gives the present embodiment after 3 courses for the treatment of, patient's transference cure, recovery from illness, so far not recurrence.
Claims (2)
1. a Chinese medicine composition for the treatment of chronic atrophic gastritis is characterized in that: the crude drug of getting following parts by weight: 40 parts of Radix Pseudostellariaes, 50 parts of Herba Dendrobiis, 5 parts of Radix Notoginseng, 40 parts of Rhizoma Curcumae, 40 parts of Radix Curcumaes, 20 parts of the Radix Paeoniae Albas, 40 parts of Herba Hedyotidis Diffusaes, 45 parts of Herba Taraxacis, 45 parts of Herba Scutellariae Barbataes, 10 parts of Cortex Magnoliae Officinalis, 7 parts of Herba Pogostemoniss, 7 parts of Herba Eupatoriis, 7 parts of Pericarpium Citri Reticulataes, 8 parts of the Rhizoma Pinelliaes, 8 parts of the Radix Aucklandiae, 8 parts of Fructus Amomis, 8 parts of Pollen Typhaes, 8 parts of Oletum Trogopteroris, 4 parts in Radix Glycyrrhizae; 10 parts of Ramulus Cinnamomi, 10 parts of Caulis Bambusae In Taenia, 30 parts of Rhizoma Phragmitiss, 10 parts of Fructus Aurantiis, 20 parts of 10 parts of Radix Ophiopogonis and Flos Loniceraes.
2. the preparation method of the Chinese medicine composition of a kind for the treatment of chronic atrophic gastritis as claimed in claim 1 is characterized in that: may further comprise the steps
1) gets Herba Dendrobii, Radix Notoginseng, the Radix Paeoniae Alba, Herba Hedyotidis Diffusae, Herba Taraxaci, Herba Scutellariae Barbatae, Cortex Magnoliae Officinalis, Herba Pogostemonis, Herba Eupatorii, the Rhizoma Pinelliae, the Radix Aucklandiae, Fructus Amomi, Pollen Typhae, Oletum Trogopterori, Radix Glycyrrhizae, Ramulus Cinnamomi, Caulis Bambusae In Taenia, Rhizoma Phragmitis, Radix Ophiopogonis and the Flos Lonicerae of above-mentioned weight portion, the decocting that adds 10 times of weight portions of total raw material medicine boils, leach medicinal liquid, get medicinal liquid A;
Radix Pseudostellariae, Rhizoma Curcumae, Radix Curcumae, Pericarpium Citri Reticulatae, the Fructus Aurantii of 2) getting above-mentioned weight portion are extracted respectively volatile oil, and the decocting that medicinal residues add up 5 times of weight portions of crude drug boils, and decoction liquor is centrifugal, gets supernatant, gets extracting solution B;
3) merge above-mentioned medicinal liquid A and extracting solution B, stir, get extracting solution C after the filtration;
When 4) extracting solution C being heated to 70 degrees centigrade, add step 2) volatile oil that makes, stir, make medicine.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310202162.9A CN103301400B (en) | 2013-05-28 | 2013-05-28 | A kind of Chinese medicine composition and preparation method for the treatment of chronic atrophic gastritis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310202162.9A CN103301400B (en) | 2013-05-28 | 2013-05-28 | A kind of Chinese medicine composition and preparation method for the treatment of chronic atrophic gastritis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103301400A true CN103301400A (en) | 2013-09-18 |
| CN103301400B CN103301400B (en) | 2016-01-13 |
Family
ID=49127406
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310202162.9A Expired - Fee Related CN103301400B (en) | 2013-05-28 | 2013-05-28 | A kind of Chinese medicine composition and preparation method for the treatment of chronic atrophic gastritis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103301400B (en) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103495039A (en) * | 2013-09-30 | 2014-01-08 | 武汉鸿信通科技有限公司 | Preparation method of spleen-strengthening and digestion-promoting traditional Chinese medicine capsules |
| CN104367913A (en) * | 2014-10-30 | 2015-02-25 | 张恩荣 | Pharmaceutical composition for treating superficial gastritis as well as preparation method thereof |
| CN104524516A (en) * | 2014-12-29 | 2015-04-22 | 安徽中医药大学第一附属医院 | Traditional Chinese medicine composition for treating liver stagnation and spleen deficiency type chronic atrophic gastritis |
| CN104771742A (en) * | 2015-04-24 | 2015-07-15 | 王永帮 | Traditional Chinese medicine composition for treating stomachache |
| CN105664120A (en) * | 2014-04-01 | 2016-06-15 | 李泉 | Traditional Chinese medicine for treating chronic atrophic gastritis |
| CN114404549A (en) * | 2022-01-29 | 2022-04-29 | 南京中医药大学 | A kind of traditional Chinese medicine composition for treating chronic atrophic gastritis and preparation method thereof |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1981860A (en) * | 2005-12-16 | 2007-06-20 | 佛山德众药业有限公司 | Chinese-medicinal composition for treating chronic gastritis and atrophic gastritis and its production |
| CN101912564A (en) * | 2010-09-07 | 2010-12-15 | 董宇翔 | Traditional Chinese medicine for treating chronic gastritis |
| CN101940734A (en) * | 2010-09-03 | 2011-01-12 | 荣成市新技术应用研究所 | Traditional Chinese medicine for treating chronic gastritis |
-
2013
- 2013-05-28 CN CN201310202162.9A patent/CN103301400B/en not_active Expired - Fee Related
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1981860A (en) * | 2005-12-16 | 2007-06-20 | 佛山德众药业有限公司 | Chinese-medicinal composition for treating chronic gastritis and atrophic gastritis and its production |
| CN101940734A (en) * | 2010-09-03 | 2011-01-12 | 荣成市新技术应用研究所 | Traditional Chinese medicine for treating chronic gastritis |
| CN101912564A (en) * | 2010-09-07 | 2010-12-15 | 董宇翔 | Traditional Chinese medicine for treating chronic gastritis |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103495039A (en) * | 2013-09-30 | 2014-01-08 | 武汉鸿信通科技有限公司 | Preparation method of spleen-strengthening and digestion-promoting traditional Chinese medicine capsules |
| CN103495039B (en) * | 2013-09-30 | 2015-10-28 | 武汉鸿信通科技有限公司 | A kind of preparation method of strengthening the spleen to promote digestion Chinese medicinal capsule |
| CN105664120A (en) * | 2014-04-01 | 2016-06-15 | 李泉 | Traditional Chinese medicine for treating chronic atrophic gastritis |
| CN104367913A (en) * | 2014-10-30 | 2015-02-25 | 张恩荣 | Pharmaceutical composition for treating superficial gastritis as well as preparation method thereof |
| CN104524516A (en) * | 2014-12-29 | 2015-04-22 | 安徽中医药大学第一附属医院 | Traditional Chinese medicine composition for treating liver stagnation and spleen deficiency type chronic atrophic gastritis |
| CN104771742A (en) * | 2015-04-24 | 2015-07-15 | 王永帮 | Traditional Chinese medicine composition for treating stomachache |
| CN114404549A (en) * | 2022-01-29 | 2022-04-29 | 南京中医药大学 | A kind of traditional Chinese medicine composition for treating chronic atrophic gastritis and preparation method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103301400B (en) | 2016-01-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103301400B (en) | A kind of Chinese medicine composition and preparation method for the treatment of chronic atrophic gastritis | |
| CN104523865A (en) | Medicine for treating breast diseases | |
| CN102846770A (en) | Pure traditional Chinese medicine capsules for treating constipation | |
| CN102579677B (en) | Chinese medicinal composition for treating brain glioma | |
| CN103446545B (en) | Traditional Chinese medicine composition for treating chronic atrophic gastritis and preparation method thereof | |
| CN104082743A (en) | Healthcare food for curing acute gouty arthritis and preparation method thereof | |
| CN103041233A (en) | Pharmaceutical composition for treating infantile diarrhea and preparation method thereof | |
| CN101502597B (en) | Medicament for treating stomachache and preparation method thereof | |
| CN105521332A (en) | Traditional Chinese medicinal composition for treating anal fissure, and preparation method and application thereof | |
| CN104622995A (en) | Pharmaceutical composition for treating chronic superficial gastritis and preparation method of pharmaceutical composition | |
| CN104688999A (en) | Chinese herbal preparation for immunity enhancement | |
| CN110841007B (en) | Traditional Chinese medicine composition for treating cerebral apoplexy sequela and application thereof | |
| CN102580053B (en) | Traditional Chinese medicine formulation for preventing and treating cancer | |
| CN102836405B (en) | Medicament for treating encephaloma | |
| CN1286515C (en) | Medicinal composition for treating cyst | |
| CN105770374A (en) | Traditional Chinese medicine composition for treating uterine fibroid | |
| CN104510835A (en) | Traditional Chinese medicinal formula for treating intestinal tumor | |
| CN105079661A (en) | Traditional Chinese medicine composition for treating hemafecia | |
| CN105687656A (en) | Pharmaceutical composition for treating myelitis and preparation method thereof | |
| CN105412529A (en) | Pharmaceutical preparation containing argy wormwood leaves and used for preventing and treating pediatric intestinal parasites as well as preparation method of pharmaceutical preparation | |
| CN104666922A (en) | Chinese medicinal composition for treating irregular menstruation due to deficiency of qi in spleen and kidney | |
| CN104367896A (en) | Pharmaceutical composition for treating qi deficiency and blood stasis-type apoplexy and preparation method thereof | |
| CN101129727B (en) | Orally taken traditional Chinese medicine composition for treating intercostal neurodynia | |
| CN103463569A (en) | Traditional Chinese medicine preparation for treating duodenal ulcer | |
| CN115006495A (en) | Chinese medicinal prescription for treating cough caused by virus |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20160113 Termination date: 20160528 |